Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19
Hüseyin Can, Ahmet Efe Köseoğlu, Sedef Erkunt Alak, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Construction of a multiepitope vaccine candidate against Fasciola hepatica : an in silico design using various immunogenic excretory/secretory antigens
Mesut Akıl, Mehmet Aykur, Muhammet Karakavuk, et al.
Expert Review of Vaccines (2021) Vol. 21, Iss. 7, pp. 993-1006
Closed Access | Times Cited: 10
Optimizing peptide inhibitors of SARS-Cov-2 nsp10/nsp16 methyltransferase predicted through molecular simulation and machine learning
John Hamre, M. Saleet Jafri
Informatics in Medicine Unlocked (2022) Vol. 29, pp. 100886-100886
Open Access | Times Cited: 7
Designing of a new multi-epitope vaccine against Leishmania major using Leish-F1 epitopes: An In-silico study
Mahsa Rabienia, Nahid Mortazavidehkordi, Zahra Roudbari, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0295495-e0295495
Open Access | Times Cited: 1
Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants
Nur Farhanah Arshad, Fariza Juliana Nordin, Lian Chee Foong, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0306111-e0306111
Open Access | Times Cited: 1
Computational identification of monkeypox virus epitopes to generate a novel vaccine antigen against Mpox
Özge Dülek, Gökhan M. Mutlu, Ecem Su Koçkaya, et al.
Biologicals (2024) Vol. 88, pp. 101798-101798
Closed Access | Times Cited: 1
Bioinformatics analysis to design a multi-epitope mRNA vaccine against S. agalactiae exploiting pathogenic proteins
Mahdi Barazesh, Maryam Abbasi, Mohsen Mohammadi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Siqi Zhuang, Lingli Tang, Yufeng Dai, et al.
PeerJ (2021) Vol. 9, pp. e11232-e11232
Open Access | Times Cited: 8
SARS-CoV-2 Spike-Derived Peptides Presented by HLA Molecules
Andrea Nguyen, Christopher Szeto, Dhilshan Jayasinghe, et al.
Biophysica (2021) Vol. 1, Iss. 2, pp. 194-203
Open Access | Times Cited: 8
In silico discovery of epitopes of gag and env proteins for the development of a multi-epitope vaccine candidate against Maedi Visna Virus using reverse vaccinology approach
Ecem Su Koçkaya, Hüseyin Can, Yalçın Yaman, et al.
Biologicals (2023) Vol. 84, pp. 101715-101715
Closed Access | Times Cited: 3
Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge
Santos B. S. A. S., João Luís Reis-Cunha, Isadora C. Carvalho, et al.
RSC Advances (2022) Vol. 12, Iss. 49, pp. 31711-31728
Open Access | Times Cited: 5
Utility of in silico-identified-peptides in spike-S1 domain and nucleocapsid of SARS-CoV-2 for antibody detection in COVID-19 patients and antibody production
Karen Cortés-Sarabia, Víctor M. Luna-Pineda, Hugo Alberto Rodríguez-Ruiz, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
In-Silico Design of Envelope based Multi-epitope Vaccine Candidate Against Kyasanur Forest Disease Virus
Sathishkumar Arumugam
Research Square (Research Square) (2021)
Open Access | Times Cited: 4
SARS-CoV-2 variants infectivity prediction and therapeutic peptide design using computational approaches
Chandran S. Abhinand, Athira A. Prabhakaran, Anand Krishnamurthy, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 11166-11177
Closed Access | Times Cited: 3
A Novel Multi-epitope Vaccine Against SARS-CoV-2 Variants of Concern Strains Applying Immunoinformatics Approaches
Samaneh Jahandar-Lashaki, Safar Farajnia, Morteza Milani, et al.
ImmunoAnalysis (2023) Vol. 3, pp. 7-7
Open Access | Times Cited: 1
Design of a multi-epitope vaccine using HA and M1 proteins from influenza and S, E, and M proteins from SARS-CoV-2 by in silico tools
Sharareh Jamali, Zahra Zamanzadeh, Azizeh Asadzadeh, et al.
Informatics in Medicine Unlocked (2023) Vol. 43, pp. 101397-101397
Open Access | Times Cited: 1
Oligomer formation of SARS-CoV-2 ORF8 through 73YIDI76 motifs regulates immune response and non-infusion antiviral interactions
Mohammad Assadizadeh, Maryam Azimzadeh Irani
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 1
Bioinformatic Identification of Conserved Epitopes from Sars-Cov-2 Genome Isolated in Kenya
Elius Mbogori, Stanslaus Musyoki, Richard Biegon, et al.
(2024)
Closed Access
VOE: automated analysis of variant epitopes of SARS-CoV-2 for the development of diagnostic tests or vaccines for COVID-19
Danusorn Lee, Unitsa Sangket
PeerJ (2024) Vol. 12, pp. e17504-e17504
Open Access
Expression, Purification, and Evaluation of Antibody Responses and Antibody-Immunogen Complex Simulation of a Designed Multi-Epitope Vaccine against SARS-COV-2
Ghadir A. Jamal, Ehsan Jahangirian, Hossein Tarrahimofrad
Protein and Peptide Letters (2024) Vol. 31, Iss. 8, pp. 619-638
Closed Access
Identification of potential antigenic proteins and epitopes for the development of a monkeypox virus vaccine: an in silico approach
Emre Aktaş, Uğur Sezerman, Murat Özer, et al.
Molecular Diversity (2024)
Closed Access
Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19?
Rachana Banerjee, Kausik Basak, Anamika Ghosh, et al.
Infection Genetics and Evolution (2021) Vol. 92, pp. 104874-104874
Open Access | Times Cited: 3
Can the immune system be targeted to treat COVID-19?
Sarah Abdelhafeez, Derek G. Doherty
COVID (2021)
Closed Access | Times Cited: 3
Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics
Steven Odongo, Hedmon Okella, Christian Ndekezi, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0279428-e0279428
Open Access | Times Cited: 2
ORF8 and Health Complications of COVID-19 in Down Syndrome Patients
Antonio Bensussen, Antonio Valcarcel, Elena Álvarez‐Buylla, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 1
In silico study on the effects of disulfide bonds in ORF8 of SARS-CoV-2
Yadi Cheng, Xubiao Peng
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 1

Scroll to top